Agenda

These meetings will be recorded and posted under each sessions agenda within 2-weeks of the meeting. After the meeting, a survey will be available to submit any questions you may have.

Welcome and Introduction of meeting format
Ben Churn, PhD NINDS

Session Chair:  Aristea Galanopoulou, MD PhD (Albert Einstein College of Medicine)

Introduction of Problem (10 min, each)

Preclinical model development and what they model 
Ed Dixon, PhD (University of Pittsburgh)

Clinical Perspective, what do we want modelled?
Ramon Diaz-Arrastia MD Phd (University of Pennsylvania)

Panel Discussants:

Asla Pitkänen, MD PhD Dsc. (University of Eastern Finland)
John Wolf PhD (University of Pennsylvania)

Chair Summation of Discussion

Format:  Topics will be introduced during the 10 min presentations.  The panel will then convene and discuss the prescient issues around the questions. All session discussions will be moderated by session chairs.

Welcome and Introduction of meeting format
Ben Churn, PhD NINDS

Session Chair:  Claudia Robertson, MD (Baylor)

Introduction of Problem (10 min each)

Challenges for preclinical studies of PTE; What mechanisms to focus upon
Victoria Johnson, MBChB, PhD.   (U. Penn)

Challenges for Clinical Studies of PTE; what is needed from preclinical studies
Pavel Klein, MD (Mid-Atlantic Epilepsy and Sleep Center)

Panel Discussants:

Amy Wagner, MD (University of Pittsburgh)
Harald Sontheimer, PhD (University of Virginia)
David Okonkwo, Md PhD (University of Pittsburgh)
Candace Floyd, PhD. (University of Utah)

Chair Summation of Discussion

Format:  Topics will be introduced during the 10 min presentations.  The panel will then convene and discuss the prescient issues around the questions. All session discussions will be moderated by session chairs.

Welcome and Introduction of meeting format
Ben Churn, PhD NINDS

Session Chair – Aristea Galanopoulou, MD PhD (Albert Einstein College of Medicine)

Introduction of Problem (10 min each)

Preclinical Biomarker Definition and Utility
Jerome (Pete) Engel, MD PhD (UCLA)

Clinical Utility for PTE Biomarkers
Paul Vespa, MD (UCLA)

Panel Discussants:

Neil Harris, PhD (UCLA)
Denes Agosten, MD PhD (Uniformed Services University)
Lisa Coles, PhD (University of Minnesota)
David Henshall, PhD (Royal college of Surgeons)

Chair Summation of Discussion

Format:  Topics will be introduced during the 10 min presentations.  The panel will then convene and discuss the prescient issues around the questions. All session discussions will be moderated by session chairs.

Welcome and Introduction of meeting format
Ben Churn, PhD   NINDS

Session Chair: Claudia Robertson, MD (Baylor)

Introduction of Problem (10 min each)

Natural History and Risk Factors for TBI and PTE
David Okonkwo, MD PhD (University of Pittsburgh)

Public Engagement
Solomon (Nico) Moshe’ (Albert Einstein College of Medicine)

Overview of Current Data Collection and Standard of Care
Geoff Manley, MD PhD (UCSF)

Pre-clinical and Translational Trials
Aristea Galanopoulou, MD PhD (Albert Einstein College of Medicine)

Panel Discussants:

Paul Vespa, MD (UCLA)
Jerome (Pete) Engel, MD PhD (UCLA)
Terence O’Brien MD (Monash University)
Uzma Samadani, MD (University of Minnesota)

Chair Summation of Discussion

Format:  Topics will be introduced during the 10 min presentations.  The panel will then convene and discuss the prescient issues around the questions. All session discussions will be moderated by session chairs.